| Literature DB >> 27448773 |
Takashi Fujiwara1, Kasumi Ohira1, Ko Urushibara2, Akihiro Ito3, Minoru Yoshida4, Misae Kanai2, Aya Tanatani2, Hiroyuki Kagechika1, Tomoya Hirano5.
Abstract
Set7/9 is a histone lysine methyltransferase, but it is also thought to be involved in a wide variety of pathophysiological functions. We previously identified cyproheptadine, which has a characteristic butterfly-like molecular conformation with bent tricyclic dibenzosuberene and chair-form N-methylpiperidine moieties, as a Set7/9 inhibitor. In this work, we synthesized several derivatives in order to examine the steric structure-inhibitory activity relationship. We found that even a small change of molecular shape due to reduction or replacement of the 10,11-olefinic bond of the tricyclic ring generally resulted in a drastic decrease of the inhibitory activity. Our results should be useful not only for development of more potent and selective inhibitors, but also for the construction of novel inhibitor scaffolds.Entities:
Keywords: Cyproheptadine; Epigenetics; Histone methyltransferase; Inhibitor; Set7/9
Mesh:
Substances:
Year: 2016 PMID: 27448773 DOI: 10.1016/j.bmc.2016.07.024
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641